Mucormycosis continues to be associated with a high mortality rate. Polymerase chain reaction may speed diagnosis and allow earlier initiation of therapy. There appears to be no evidence supporting the use of combination as opposed to single agent (liposomal amphotericin B) therapy.
ABSTRACT & COMMENTARY
Mucormycosis Remains Highly Lethal
November 1, 2024